Regulation of mRNA translation by MID1: A common mechanism of expanded CAG repeat RNAs

Frontiers in Cellular Neuroscience

Volumn 10, Issue OCT2016, 2016, Pages

  Griesche, Nadine ^a   Schilling, Judith ^a   Weber, Stephanie ^a   Rohm, Marlena ^a   Pesch, Verena ^a   Matthes, Frank ^a   Auburger, Georg ^b   Krauss, Sybille ^a  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

CAG repeat expansion; MID1; Polyglutamine diseases; RNA binding proteins; RNA toxicity

Indexed keywords

ATAXIN 2; ATAXIN 3; ATAXIN 7; ENHANCED GREEN FLUORESCENT PROTEIN; FIREFLY LUCIFERASE; HUNTINGTIN; MESSENGER RNA; MID1 PROTEIN; PEPTIDES AND PROTEINS; PHOSPHOPROTEIN PHOSPHATASE 2A; POLYGLUTAMINE; RNA BINDING PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CAG REPEAT; CONTROLLED STUDY; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GENE SEQUENCE; HEK293 CELL LINE; HELA CELL LINE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN SECONDARY STRUCTURE; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSLATION REGULATION; WESTERN BLOTTING;

EID: 84991712475     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2016.00226     Document Type: Article

References (39)

1. Aranda-Orgillés, B., Rutschow, D., Zeller, R., Karagiannidis, A. I., Köhler, A., Chen, C., et al. (2011). Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1). J. Biol. Chem. 286, 39945-39957. doi: 10.1074/jbc.M111.224451
2. Bañez-Coronel, M., Porta, S., Kagerbauer, B., Mateu-Huertas, E., Pantano, L., Ferrer, I., et al. (2012). A pathogenic mechanism in Huntington’s disease involves small CAG-repeated RNAs with neurotoxic activity. PLoS Genet. 8:e1002481. doi: 10.1371/journal.pgen.1002481
3. Bañez-Coronel, M., Ayhan, F., Tarabochia, A. D., Zu, T., Perez, B., A., Tusi, S. K., et al. (2015). RAN translation in Huntington disease. Neuron 88, 667-677. doi: 10.1016/j.neuron.2015.10.038
4. Boudreau, R. L., McBride, J. L., Martins, I., Shen, S., Xing, Y., Carter, B. J., et al. (2009). Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington’s disease mice. Mol. Ther. 17, 1053-1063. doi: 10.1038/mt.2009.17
5. Busan, S., and Weeks, K. M. (2013). Role of context in RNA structure: flanking sequences reconfigure CAG motif folding in huntingtin exon 1 transcripts. Biochemistry 52, 8219-8225. doi: 10.1021/bi401129r
6. Damrath, E., Heck, M. V., Gispert, S., Azizov, M., Nowock, J., Seifried, C., et al. (2012). ATXN2-CAG42 sequesters PABPC1 into insolubility and induces FBXW8 in cerebellum of old ataxic knock-in mice. PLoS Genet. 8:e1002920. doi: 10.1371/journal.pgen.1002920
7. Davies, J. E., and Rubinsztein, D. C. (2006). Polyalanine and polyserine frameshift products in Huntington’s disease. J. Med. Genet. 43, 893-896. doi: 10.1136/jmg.2006.044222
8. de Mezer, M., Wojciechowska, M., Napierala, M., Sobczak, K., and Krzyzosiak, W. J. (2011). Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference. Nucleic Acids Res. 39, 3852-3863. doi: 10.1093/nar/gkq1323
9. Fiszer, A., and Krzyzosiak, W. J. (2014). Oligonucleotide-based strategies to combat polyglutamine diseases. Nucleic Acids Res. 42, 6787-6810. doi: 10.1093/nar/gku385
10. Gaspar, C., Jannatipour, M., Dion, P., Laganière, J., Sequeiros, J., Brais, B., et al. (2000). CAG tract of MJD-1 may be prone to frameshifts causing polyalanine accumulation. Hum. Mol. Genet. 9, 1957-1966. doi: 10.1093/hmg/9.13.1957
11. Hettich, M. M., Matthes, F., Ryan, D. P., Griesche, N., Schröder, S., Dorn, S., et al. (2014). The anti-diabetic drug metformin reduces BACE1 protein level by interfering with the MID1 complex. PLoS ONE 9:e102420. doi: 10.1371/journal.pone.0102420
12. Kickstein, E., Krauss, S., Thornhill, P., Rutschow, D., Zeller, R., Sharkey, J., et al. (2010). Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proc. Natl. Acad. Sci. U.S.A. 107, 21830-21835. doi: 10.1073/pnas.0912793107
13. Kiliszek, A., Kierzek, R., Krzyzosiak, W. J., and Rypniewski, W. (2010). Atomic resolution structure of CAG RNA repeats: structural insights and implications for the trinucleotide repeat expansion diseases. Nucleic Acids Res. 38, 8370-8376. doi: 10.1093/nar/gkq700
14. Koch, P., Breuer, P., Peitz, M., Jungverdorben, J., Kesavan, J., Poppe, D., et al. (2011). Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease. Nature 480, 543-546. doi: 10.1038/nature10671
15. Köhler, A., Demir, Ü., Kickstein, E., Krauss, S., Aigner, J., Aranda-Orgilles, B., et al. (2014). A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling. Mol. Cancer 13:146. doi: 10.1186/1476-4598-13-146
16. Krauss, S., Griesche, N., Jastrzebska, E., Chen, C., Rutschow, D., Achmuller, C., et al. (2013). Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex. Nat. Commun. 4:1511. doi: 10.1038/ncomms2514
17. Krol, J., Fiszer, A., Mykowska, A., Sobczak, K., de Mezer, M., and Krzyzosiak, W. J. (2007). Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol. Cell 25, 575-586. doi: 10.1016/j.molcel.2007.01.031
18. Li, L. B., Yu, Z., Teng, X., and Bonini, N. M. (2008). RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature 453, 1107-1111. doi: 10.1038/nature06909
19. Liu, E., Knutzen, C. A., Krauss, S., Schweiger, S., and Chiang, G. G. (2011). Control of mTORC1 signaling by the Opitz syndrome protein MID1. Proc. Natl. Acad. Sci. U.S.A. 108, 8680-8685. doi: 10.1073/pnas.1100131108
20. Mathews, D. H., Sabina, J., Zuker, M., and Turner, D. H. (1999). Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol. 288, 911-940. doi: 10.1006/jmbi.1999.2700
21. McLaughlin, B. A., Spencer, C., and Eberwine, J. (1996). CAG trinucleotide RNA repeats interact with RNA-binding proteins. Am. J. Hum. Genet. 59, 561-569.
22. Michlewski, G., and Krzyzosiak, W. J. (2004). Molecular architecture of CAG repeats in human disease related transcripts. J. Mol. Biol. 340, 665-679. doi: 10.1016/j.jmb.2004.05.021
23. Mykowska, A., Sobczak, K., Wojciechowska, M., Kozlowski, P., and Krzyzosiak, W. J. (2011). CAG repeats mimic CUG repeats in the misregulation of alternative splicing. Nucleic Acids Res. 39, 8938-8951. doi: 10.1093/nar/gkr608
24. Nalavade, R., Griesche, N., Ryan, D. P., Hildebrand, S., and Krauss, S. (2013). Mechanisms of RNA-induced toxicity in CAG repeat disorders. Cell Death Dis. 4:e752. doi: 10.1038/cddis.2013.276
25. Rudnicki, D. D., and Margolis, R. L. (2003). Repeat expansion and autosomal dominant neurodegenerative disorders: consensus and controversy. Expert Rev. Mol. Med. 5, 1-24. doi: 10.1017/s1462399403006598
26. Schilling, J., Griesche, N., and Krauß, S. (2016). Mechanisms of RNA-induced toxicity in diseases characterised by CAG repeat expansions. eLS 1-8. doi: 10.1002/9780470015902.a0026464
27. Shao, J., and Diamond, M. I. (2007). Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum. Mol. Genet. 2, R115-R123. doi: 10.1093/hmg/ddm213
28. Sobczak, K., de Mezer, M., Michlewski, G., Krol, J., and Krzyzosiak, W. J. (2003). RNA structure of trinucleotide repeats associated with human neurological diseases. Nucleic Acids Res. 31, 5469-5482. doi: 10.1093/nar/gkg766
29. Sobczak, K., and Krzyzosiak, W. J. (2005). CAG repeats containing CAA interruptions form branched hairpin structures in spinocerebellar ataxia type 2 transcripts. J. Biol. Chem. 280, 3898-3910. doi: 10.1074/jbc.M409984200
30. Stochmanski, S. J., Therrien, M., Laganière, J., Rochefort, D., Laurent, S., Karemera, L., et al. (2012). Expanded ATXN3 frameshifting events are toxic in Drosophila and mammalian neuron models. Hum. Mol. Genet. 21, 2211-2218. doi: 10.1093/hmg/dds036
31. Toulouse, A., Au-Yeung, F., Gaspar, C., Roussel, J., Dion, P., and Rouleau, G. A. (2005). Ribosomal frameshifting on MJD-1 transcripts with long CAG tracts. Hum. Mol. Genet. 14, 2649-2660. doi: 10.1093/hmg/ddi299
32. Trockenbacher, A., Suckow, V., Foerster, J., Winter, J., Krauss, S., Ropers, H.-H., et al. (2001). MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat. Genet. 29, 287-294. doi: 10.1038/ng762
33. Tsoi, H., and Chan, H. Y. E. (2013). Expression of expanded CAG transcripts triggers nucleolar stress in Huntington’s disease. Cerebellum 12, 310-312. doi: 10.1007/s12311-012-0447-6
34. Tsoi, H., Lau, T. C., Tsang, S. Y., Lau, K. F., and Chan, H. Y. (2012). CAG expansion induces nucleolar stress in polyglutamine diseases. Proc. Natl. Acad. Sci. U.S.A. 109, 13428-13433. doi: 10.1073/pnas.1204089109
35. Yamamoto, A., Lucas, J. J., and Hen, R. (2000). Reversal of neuropathology and motor dysfunction in a conditional model of Huntington’s disease. Cell 101, 57-66. doi: 10.1016/S0092-8674(00)80623-6
36. Yuan, Y., Compton, S. A., Sobczak, K., Stenberg, M G., Thornton, C. A., Griffith, J. D., et al. (2007). Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res. 35, 5474-5486. doi: 10.1093/nar/gkm601
37. Zhang, Y., and Friedlander, R. M. (2011). Using non-coding small RNAs to develop therapies for Huntington’s disease. Gene Ther. 18, 1139-1149. doi: 10.1038/gt.2011.170
38. Zu, T., Gibbens, B., Doty, N. S., Gomes-Pereira, M., Huguet, A., Stone, M. D. et al. (2011). Non-ATG-initiated translation directed by microsatellite expansions. Proc. Natl. Acad. Sci. U.S.A. 108, 260-265. doi: 10.1073/pnas.1013343108
39. Zuker, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406-3415. doi: 10.1093/nar/gkg595